Literature DB >> 12097320

Human T-cell lymphotropic virus type 1 tax inhibits transforming growth factor-beta signaling by blocking the association of Smad proteins with Smad-binding element.

Dug Keun Lee1, Byung-Chul Kim, John N Brady, Kuan-Teh Jeang, Seong-Jin Kim.   

Abstract

The human T-cell lymphotropic virus type 1 (HTLV-1) oncoprotein Tax is implicated in various clinical manifestations associated with infection by HTLV-1, including an aggressive and fatal T-cell malignancy. Because many human HTLV-1-infected T-cell lines are resistant to the growth inhibitory activity of transforming growth factor beta (TGF-beta), we examined the possibility that the HTVL-1-Tax oncoprotein regulates TGF-beta signaling. We show that Tax significantly decreases transcriptional activity and growth inhibition in response to TGF-beta. Tax inhibits TGF-beta-induced plasminogen activator inhibitor-1 expression and Smad2 phosphorylation. Competitive interaction studies show that Tax inhibits TGF-beta signaling, in part, by disrupting the interaction of the Smads with the transcriptional co-activator p300. Tax directly interacts with Smad2, Smad3, and Smad4; the Smad MH2 domain binds to Tax. Furthermore, Tax inhibits Smad3.Smad4 complex formation and its DNA binding. These results suggest that suppression of Smad-mediated signaling by Tax may contribute to HTLV-1-associated leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12097320     DOI: 10.1074/jbc.M200150200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Kaposi's sarcoma-associated herpesvirus-encoded microRNA miR-K12-11 attenuates transforming growth factor beta signaling through suppression of SMAD5.

Authors:  Yunhua Liu; Rui Sun; Xianzhi Lin; Deguang Liang; Qiang Deng; Ke Lan
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

2.  HTLV-1 bZIP factor enhances TGF-β signaling through p300 coactivator.

Authors:  Tiejun Zhao; Yorifumi Satou; Kenji Sugata; Paola Miyazato; Patrick L Green; Takeshi Imamura; Masao Matsuoka
Journal:  Blood       Date:  2011-06-24       Impact factor: 22.113

3.  Human papillomavirus type 5 E6 oncoprotein represses the transforming growth factor beta signaling pathway by binding to SMAD3.

Authors:  Jose-Andres Mendoza; Yves Jacob; Patricia Cassonnet; Michel Favre
Journal:  J Virol       Date:  2006-10-04       Impact factor: 5.103

4.  Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence.

Authors:  Abhik Datta; Marcia Bellon; Uma Sinha-Datta; Ali Bazarbachi; Yves Lepelletier; Danielle Canioni; Thomas A Waldmann; Olivier Hermine; Christophe Nicot
Journal:  Blood       Date:  2006-03-28       Impact factor: 22.113

Review 5.  Leukemogenesis of adult T-cell leukemia.

Authors:  Jun-ichirou Yasunaga; Masao Matsuoka
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

Review 6.  T-cell control by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Risaku Fukumoto; Jake R Fullen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

7.  Transforming growth factor beta1 receptor II is downregulated by E1A in adenovirus-infected cells.

Authors:  Vera L Tarakanova; William S M Wold
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

8.  Tax relieves transcriptional repression by promoting histone deacetylase 1 release from the human T-cell leukemia virus type 1 long terminal repeat.

Authors:  Hanxin Lu; Cynthia A Pise-Masison; Rebecca Linton; Hyeon Ung Park; R Louis Schiltz; Vittorio Sartorelli; John N Brady
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

9.  A Kaposi's sarcoma-associated herpesvirus microRNA and its variants target the transforming growth factor β pathway to promote cell survival.

Authors:  Xiufen Lei; Ying Zhu; Tiffany Jones; Zhiqiang Bai; Yufei Huang; Shou-Jiang Gao
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

Review 10.  Role of transforming growth factor-beta in hematologic malignancies.

Authors:  Mei Dong; Gerard C Blobe
Journal:  Blood       Date:  2006-02-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.